Publication related to RSI or an RSI staff member

Nonparticipation Selection Bias in the MOBI-Kids Study.

BACKGROUND: MOBI-Kids is a 14-country case-control study designed to investigate the potential effects of electromagnetic field exposure from mobile telecommunications devices on brain tumor risk in children and young adults conducted from 2010 to 2016. This work describes differences in cellular telephone use and personal characteristics among interviewed participants and refusers responding to a brief nonrespondent questionnaire. It also assesses the potential impact of nonparticipation selection bias on study findings. METHODS: We compared nonrespondent questionnaires completed by 77 cases and 498 control refusers with responses from 683 interviewed cases and 1501 controls (suspected appendicitis patients) in six countries (France, Germany, Israel, Italy, Japan, and Spain). We derived selection bias factors and estimated inverse probability of selection weights for use in analysis of MOBI-Kids data. RESULTS: The prevalence of ever-regular use was somewhat higher among interviewed participants than nonrespondent questionnaire respondents 10-14 years of age (68% vs. 62% controls, 63% vs. 48% cases); in those 20-24 years, the prevalence was >/=97%. Interviewed controls and cases in the 15- to 19- and 20- to 24-year-old age groups were more likely to have a time since start of use of 5+ years. Selection bias factors generally indicated a small underestimation in cellular telephone odds ratios (ORs) ranging from 0.96 to 0.97 for ever-regular use and 0.92 to 0.94 for time since start of use (5+ years), but varied in alternative hypothetical scenarios considered. CONCLUSIONS: Although limited by small numbers of nonrespondent questionnaire respondents, findings generally indicated a small underestimation in cellular telephone ORs due to selective nonparticipation.

Authors

  • Turner, Michelle C, Turner MC, From the Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.; Universitat Pompeu Fabra (UPF), Barcelona, Spain.; CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.; McLaughlin Centre for Population Health Risk Assessment, University of Ottawa, Ottawa, Canada.

  • Gracia-Lavedan, Esther, Gracia-Lavedan E, From the Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.; Universitat Pompeu Fabra (UPF), Barcelona, Spain.; CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

  • Momoli, Franco, Momoli F, Ottawa Hospital Research Institute, Ottawa, Canada.; Children's Hospital of Eastern Ontario Research Institute, Ottawa, Canada.; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.

  • Langer, Chelsea E, Langer CE, From the Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.; Universitat Pompeu Fabra (UPF), Barcelona, Spain.; CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

  • Castano-Vinyals, Gemma, Castano-Vinyals G, From the Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.; Universitat Pompeu Fabra (UPF), Barcelona, Spain.; CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.

  • Kundi, Michael, Kundi M, Institute of Environmental Health, Medical University of Vienna, Vienna, Austria.

  • Maule, Milena, Maule M, Unit of Cancer Epidemiology, Department of Medical Sciences, University of Turin, Turin, Italy.

  • Merletti, Franco, Merletti F, Unit of Cancer Epidemiology, Department of Medical Sciences, University of Turin, Turin, Italy.

  • Sadetzki, Siegal, Sadetzki S, Cancer & Radiation Epidemiology Unit, Gertner Institute, Chaim Sheba Medical Center, Ramat Gan, Israel.; Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

  • Vermeulen, Roel, Vermeulen R, Division of Environmental Epidemiology, Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands.

  • Albert, Alex, Albert A, From the Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.; Universitat Pompeu Fabra (UPF), Barcelona, Spain.; CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

  • Alguacil, Juan, Alguacil J, CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.; Research Center on Natural Resources, Health and Environment (RENSMA), Huelva University, Huelva, Spain.

  • Aragones, Nuria, Aragones N, CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.; Epidemiology Section, Public Health Division, Department of Health, Madrid, Spain.

  • Badia, Francesc, Badia F, From the Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.; Universitat Pompeu Fabra (UPF), Barcelona, Spain.; CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

  • Bruchim, Revital, Bruchim R, Cancer & Radiation Epidemiology Unit, Gertner Institute, Chaim Sheba Medical Center, Ramat Gan, Israel.

  • Carretero, Gema, Carretero G, From the Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.; Universitat Pompeu Fabra (UPF), Barcelona, Spain.; CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

  • Kojimahara, Noriko, Kojimahara N, Department of Public Health, Tokyo Women's Medical University, Tokyo, Japan.

  • Lacour, Brigitte, Lacour B, French National Registry of Childhood Solid Tumors, CHU, Nancy, France.; Inserm U1153, Epidemiology and Biostatistics Sorbonne Paris Cité Centre (CRESS), Epidemiology of Childhood and Adolescent Cancers Team (EPICEA), Paris, France.

  • Morales-Suarez-Varela, Maria, Morales-Suarez-Varela M, CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.; Área de Medicina Preventiva y Salud Pública, Universitat de Valencia, Valencia, Spain.

  • Radon, Katja, Radon K, Institute and Clinic for Occupational, Social and Environmental Medicine, University Hospital, LMU Munich, Munich, Germany.

  • Remen, Thomas, Remen T, French National Registry of Childhood Solid Tumors, CHU, Nancy, France.

  • Weinmann, Tobias, Weinmann T, Institute and Clinic for Occupational, Social and Environmental Medicine, University Hospital, LMU Munich, Munich, Germany.

  • Yamaguchi, Naohito, Yamaguchi N, Department of Public Health, Tokyo Women's Medical University, Tokyo, Japan.

  • Cardis, Elisabeth, Cardis E, From the Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.; Universitat Pompeu Fabra (UPF), Barcelona, Spain.; CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

YEAR OF PUBLICATION: 2019
SOURCE: Epidemiology. 2019 Jan;30(1):145-153. doi: 10.1097/EDE.0000000000000932.
JOURNAL TITLE ABBREVIATION: Epidemiology
JOURNAL TITLE: Epidemiology (Cambridge, Mass.)
ISSN: 1531-5487 (Electronic) 1044-3983 (Print) 1044-3983 (Linking)
VOLUME: 30
ISSUE: 1
PAGES: 145-153
PLACE OF PUBLICATION: United States
ABSTRACT:
BACKGROUND: MOBI-Kids is a 14-country case-control study designed to investigate the potential effects of electromagnetic field exposure from mobile telecommunications devices on brain tumor risk in children and young adults conducted from 2010 to 2016. This work describes differences in cellular telephone use and personal characteristics among interviewed participants and refusers responding to a brief nonrespondent questionnaire. It also assesses the potential impact of nonparticipation selection bias on study findings. METHODS: We compared nonrespondent questionnaires completed by 77 cases and 498 control refusers with responses from 683 interviewed cases and 1501 controls (suspected appendicitis patients) in six countries (France, Germany, Israel, Italy, Japan, and Spain). We derived selection bias factors and estimated inverse probability of selection weights for use in analysis of MOBI-Kids data. RESULTS: The prevalence of ever-regular use was somewhat higher among interviewed participants than nonrespondent questionnaire respondents 10-14 years of age (68% vs. 62% controls, 63% vs. 48% cases); in those 20-24 years, the prevalence was >/=97%. Interviewed controls and cases in the 15- to 19- and 20- to 24-year-old age groups were more likely to have a time since start of use of 5+ years. Selection bias factors generally indicated a small underestimation in cellular telephone odds ratios (ORs) ranging from 0.96 to 0.97 for ever-regular use and 0.92 to 0.94 for time since start of use (5+ years), but varied in alternative hypothetical scenarios considered. CONCLUSIONS: Although limited by small numbers of nonrespondent questionnaire respondents, findings generally indicated a small underestimation in cellular telephone ORs due to selective nonparticipation.
LANGUAGE: eng
DATE OF PUBLICATION: 2019 Jan
DATE COMPLETED: 20190325
DATE REVISED: 20200225
MESH DATE: 2019/03/26 06:00
EDAT: 2018/10/10 06:00
STATUS: MEDLINE
PUBLICATION STATUS: ppublish
LOCATION IDENTIFIER: 10.1097/EDE.0000000000000932 [doi]
OWNER: NLM

Related RSI Experts

Franco Momoli

Vice-President Chemical and Product Safety

Dr. Franco Momoli joined Risk Sciences International (RSI) in 2019 and currently serves as Vice-President, Chemical and Product Safety. In this role, he leads a multidisciplinary team of epidemiologists, risk assessors, toxicologists, and biostatisticians in conducting human health risk assessments...
Read More about Franco Momoli